SU 6668 - TSU 68 | Orantinib

Based on 20 reference(s) in Google Scholar 80 100 20

Axon 1891

CAS [252916-29-3]

MF C18H18N2O3
MW 310.35

  • Purity: 98%
  • Soluble in 0.1N NaOH(aq) and DMSO

SU 6668


An ATP-competitive, orally bioavailable receptor tyrosine kinase (RTK) inhibitor targeting PDGFR, VEGF and FGFR (IC50 values are 0.06, 2.43, 3.04 and >100 μM at PDGFRβ, VEGFR2, FGFR1 and EGFR respectively)
Size Unit Price Stock
10 mg €100.00 In Stock
50 mg €330.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...